Award

Cancer Vaccine Launch Pad (CVLP) Scale-up

  • NHS England

UK6: Contract award notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-072820

Procurement identifier (OCID): ocds-h6vhtk-05deb2 (view related notices)

Published 11 November 2025, 2:00pm



Scope

Reference

C397089

Description

NHS England issuing a Direct Award Contract to University of Southampton Clinical Trials Unit for the Cancer Vaccine Launch Pad (CVLP) Services. The initial term will be 24 months from 1 May 2026, with the potential to extend up to 3 additional years in increments.

The CVLP is a strategic priority and collaboration between NHS England, the Department of Health and Social Care (DHSC), the Office for Life Sciences (OLS), and National Institute of Health Research (NIHR), with the aim to facilitate access to personalised cancer vaccine research trials and other immunotherapies.

The programme is a scale up phase in the development, testing, and evaluation of personalised cancer vaccines and other immunotherapies through clinical trials and genomic analysis. The supplier will be responsible for clinical trial oversight, research management, facilitating strategic partnerships, consenting patients; tracking biological samples and facilitating the sharing of information between CVLP sites, research trial sites and commercial companies; hosting, maintaining and enhancing the electronic referral tool platform, and integrating with existing NHS and academic systems.

The approved procurement route to market is via Direct Contract Award, which aligns with the Cabinet Office's published guidance on exempt contracts under Schedule 2 of the Procurement Act 2023 Regulations.


Contract 1. Cancer Vaccine Launchpad (CVLP) Scale-up

Supplier

Contract value

  • £9,305,994 excluding VAT
  • £11,167,192.80 including VAT

Above the relevant threshold

Award decision date

7 November 2025

Standstill period

  • End: 20 November 2025
  • 8 working days

Earliest date the contract will be signed

15 December 2025

Contract dates (estimated)

  • 1 May 2026 to 30 April 2028
  • Possible extension to 30 April 2031
  • 5 years

Description of possible extension:

Up-to 36 months in increments

Main procurement category

Services

Options

The right to additional purchases while the contract is valid.

Option to extend if exercised by the contracting authority

CPV classifications

  • 85100000 - Health services

Contract locations

  • UK - United Kingdom

Procedure

Procedure type

Direct award


Supplier

University of Southampton Clinical Trials Unit

  • Companies House: RC000668

University Road, Highfield

Southampton

SO17 1BJ

United Kingdom

Region: UKJ32 - Southampton

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. Cancer Vaccine Launchpad (CVLP) Scale-up


Contracting authority

NHS England

  • Public Procurement Organisation Number: PDPT-3135-BWWY

7&8 Wellington Place

Leeds

LS1 4AP

United Kingdom

Contact name: NHS England

Telephone: 0300 311 2233

Email: england.commercialqueries@nhs.net

Website: https://www.england.nhs.uk//

Region: UKE42 - Leeds

Organisation type: Public authority - central government